Clinical Trials Directory

Trials / Terminated

TerminatedNCT00742313

Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic Vein Harvest (EVH)

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, randomized trial to see in patients undergoing coronary artery bypass grafting and endoscopically-harvested greater saphenous vein, if using FloSeal Matrix in the endoscopically-harvested saphenous vein wound bed decreases bleeding and complications.

Detailed description

Purpose of Study: The primary objective of this study is to determine if using a hemostatic agent (FloSeal Matrix™) in the tunnel of the endoscopically harvested Greater Saphenous vein will decrease bleeding from that site. Secondary objectives are to determine if there is a decrease in the infection-rate at the site of the vein-harvested leg where the FloSeal Matrix™ was used compared to the ones where FloSeal Matrix™ was not used. Background and Significance: FloSeal Matrix™ is indicated in surgical procedures (other than ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical. It works on wet, actively bleeding tissue and conforms to irregular wound surfaces. It is proven to control bleeding from oozing to pulsatile flow. The EVH wound bed is irregular and hemostasis is, at times, difficult to obtain using conventional procedures such as ligature or cautery. Design and Procedures: This is a prospective, randomized clinical trial that compares the effects of applying FloSeal Matrix™ to the EVH wound bed to not applying FloSeal Matrix™ to the EVH wound bed.

Conditions

Interventions

TypeNameDescription
BIOLOGICALFloSeal Matrix10 ml of FloSeal Matrix will be applied to the endoscopic wound bed.

Timeline

Start date
2009-06-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2008-08-27
Last updated
2014-03-05
Results posted
2014-03-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00742313. Inclusion in this directory is not an endorsement.